Saturday, September 23, 2023
Saturday, September 23, 2023

PAN Foundation Launches COVID-19 Treatment and Prevention Fund to Help At-Risk Medicare Beneficiaries Pay for Treatment, Groceries and Other Critical Services

PAN Foundation, is an independent charitable organization dedicated to helping underinsured patients access critical medical care. Today they announced that it will offer financial assistance to Americans with existing medical conditions who have COVID-19 or are quarantined because of the virus.

Through this comprehensive fund, PAN will provide a $300 grant to qualifying Medicare beneficiaries with cancer, chronic or rare diseases who have also been diagnosed with COVID-19 or directed to self-quarantine by their healthcare provider or a government agency. Grant recipients can use the funds for treatment co-pays, prescription and over-the-counter medications, medical supplies and other important expenses related to COVID-19 prevention and treatment, including transportation to medical appointments and groceries, meals and food delivery services.

“The COVID-19 pandemic is a stark reminder of the importance of our mission to ensure that every American can afford the healthcare they need. While we don’t know the full impact of this outbreak, we’re dedicated to doing everything we can to protect and support the most vulnerable members of our society,” said PAN President and CEO Daniel J. Klein. “As Medicare beneficiaries and people with serious health conditions learn to cope with this rapidly evolving situation, we’re committed to providing assistance to help those who need it most so they can focus on getting better and worry less about the cost of care.”

The results of a recent poll by the Commonwealth Foundation highlight the collective worry of Americans about their ability to afford medical treatment: 68 percent of adults said that the out-of-pocket costs they might have to pay would be very or somewhat important in their decision to get treatment if they had symptoms of the coronavirus.

The COVID-19 Treatment and Prevention Fund is currently open for applicants who have annual household incomes up to 400 percent of the federal poverty level. Eligible patients can learn more about the fund on our website or by calling PAN at 1-866-316-7263 from Monday through Friday, 9 a.m. to 7 p.m. ET.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy